This is a page describing data taken during an experiment at the ISIS Neutron and Muon Source. Information about the ISIS Neutron and Muon Source can be found at https://www.isis.stfc.ac.uk.
How does the anti-tumor drug paclitaxel change the dynamics on breast cancer cells?
Abstract: Cells are complex systems where small fragments play an interdependent role. The functionality of these systems can be distinct at different length and timescales, depending on physiological conditions or cells type. For example, cancer cells are more flexible than the healthy ones. Thus, understanding cancer cells flexibility is the first step to elucidate how and why they migrate and adhere to different tissues. Another point about the dynamics of cancer cells is the mechanism of action of the drug paclitaxel that bonds to the structural framework of cancer cells, the cytoskeleton, and inhibits their motions and division. Then, a cancer cell treated with paclitaxel should present changes on flexibility. Understanding such changes at distinct timescales might provide additional information on paclitaxel´s action and support the development of new and less toxic drugs.
Principal Investigator: Mr Murillo Longo Martins
Experimenter: Professor Heloisa Nunes Bordallo
Local Contact: Dr Svemir Rudic
Experimenter: Mr Jose Pereira
DOI: 10.5286/ISIS.E.RB1520341
ISIS Experiment Number: RB1520341
Part DOI | Instrument | Public release date | Download Link |
---|---|---|---|
10.5286/ISIS.E.67771272 | TOSCA | 19 November 2018 | Download |
Publisher: STFC ISIS Neutron and Muon Source
Data format: RAW/Nexus
Select the data format above to find
out more about it.
Data Citation
The recommended format for citing this dataset in a research
publication is as:
[author], [date], [title], [publisher],
[doi]
For Example:
Mr Murillo Longo Martins et al; (2015): How does the anti-tumor drug paclitaxel change the dynamics on breast cancer cells?, STFC ISIS Neutron and Muon Source, https://doi.org/10.5286/ISIS.E.RB1520341
Data is released under the CC-BY-4.0 license.